What is the price target for VITL stock?
18 analysts have analysed VITL and the average price target is 28.15 USD. This implies a price increase of 98.53% is expected in the next year compared to the current price of 14.18.
NASDAQ:VITL • US92847W1036
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VITAL FARMS INC (VITL).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-23 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2026-04-21 | Stifel | Maintains | Buy -> Buy |
| 2026-04-08 | TD Cowen | Downgrade | Buy -> Hold |
| 2026-04-02 | Craig-Hallum | Maintains | Buy -> Buy |
| 2026-03-27 | Needham | Maintains | Buy -> Buy |
| 2026-03-27 | Telsey Advisory Group | Maintains | Outperform -> Outperform |
| 2026-03-02 | Mizuho | Maintains | Outperform -> Outperform |
| 2026-03-02 | Needham | Maintains | Buy -> Buy |
| 2026-02-27 | Telsey Advisory Group | Maintains | Outperform -> Outperform |
| 2026-02-27 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2026-01-30 | Needham | Reiterate | Buy -> Buy |
| 2026-01-13 | Telsey Advisory Group | Maintains | Outperform -> Outperform |
| 2025-12-18 | TD Cowen | Maintains | Buy -> Buy |
| 2025-12-18 | DA Davidson | Maintains | Buy -> Buy |
| 2025-12-18 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-12-18 | Needham | Reiterate | Buy -> Buy |
| 2025-12-17 | Telsey Advisory Group | Maintains | Outperform -> Outperform |
| 2025-12-17 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-12-05 | Needham | Initiate | Buy |
| 2025-11-26 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-11-13 | Benchmark | Initiate | Buy |
| 2025-11-05 | Telsey Advisory Group | Maintains | Outperform -> Outperform |
| 2025-10-30 | Telsey Advisory Group | Maintains | Outperform -> Outperform |
| 2025-09-02 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-08-11 | Mizuho | Maintains | Outperform -> Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 471.857M 30.31% | 606.307M 28.49% | 759.444M 25.26% | 909.23M 19.72% | 1.064B 17.02% | 1.264B 18.80% | |
| EBITDA YoY % growth | 41.298M 328.40% | 76.645M 85.59% | 102.885M 34.24% | 106.3M 3.32% | 129.96M 22.26% | 139.32M 7.20% | |
| EBIT YoY % growth | 33.373M 694.60% | 63.552M 90.43% | 88.373M 39.06% | 81.543M -7.73% | 102.57M 25.79% | 129.25M 26.01% | |
| Operating Margin | 7.07% | 10.48% | 11.64% | 8.97% | 9.64% | 10.23% | |
| EPS YoY % growth | 0.58 625.00% | 1.18 103.45% | 1.44 22.03% | 1.18 -17.76% | 1.48 24.83% | 1.69 14.19% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.09 -75.46% | 0.23 -36.56% | 0.30 -15.82% | 0.40 13.16% | 0.28 206.52% | 0.35 51.50% | 0.32 5.82% | 0.42 6.16% | 0.02 -91.20% | 0.28 -20.11% | 0.36 12.91% | 0.43 2.86% |
| Revenue Q2Q % growth | 191.84M 18.28% | 219.84M 18.98% | 237.26M 19.26% | 259.99M 21.75% | 235.37M 22.69% | 263.78M 19.99% | 278.83M 17.52% | 303.14M 16.60% | 262.66M 11.59% | 285.38M 8.19% | 312.57M 12.10% | 345.61M 14.01% |
| EBITDA Q2Q % growth | 14.965M -40.21% | 22.238M -27.14% | 26.253M -16.29% | 31.979M -10.98% | 27.1M 81.09% | 31.585M 42.03% | 30.916M 17.76% | 36.441M 13.95% | 11.73M -56.72% | 26.826M -15.07% | 32.028M 3.60% | 36.108M -0.91% |
| EBIT Q2Q % growth | 5.709M -73.77% | 12.99M -45.41% | 18.444M -13.81% | 23.378M 9.19% | 21.42M 275.20% | 24.412M 87.93% | 21.25M 15.21% | 26.214M 12.13% | N/A | N/A | N/A | N/A |
All data in USD
18 analysts have analysed VITL and the average price target is 28.15 USD. This implies a price increase of 98.53% is expected in the next year compared to the current price of 14.18.
VITAL FARMS INC (VITL) will report earnings on 2026-05-07, before the market open.
The consensus EPS estimate for the next earnings of VITAL FARMS INC (VITL) is 0.09 USD and the consensus revenue estimate is 191.84M USD.
The consensus rating for VITAL FARMS INC (VITL) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.